Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Ning Zhao; Shu-yi Zheng; Jin-ji Yang; Xu-chao Zhang; Zhi Xie; Bin Xie; Jian Su; Zhi-hong Chen; Shi-liang Chen; Na Zhang; Na-na Lou; Song Dong; Yi-long Wu

doi:10.1016/j.cllc.2014.11.001

Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Clinical Lung Cancer ◽

10.1016/j.cllc.2014.11.001 ◽

2015 ◽

Vol 16 (2) ◽

pp. e5-e9 ◽

Cited By ~ 14

Author(s):

Ning Zhao ◽

Shu-yi Zheng ◽

Jin-ji Yang ◽

Xu-chao Zhang ◽

Zhi Xie ◽

...

Keyword(s):

Case Report ◽

Literature Review ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Mutation

Download Full-text

Variant Philadelphia t(X;9;22)(q22?;q34;q11.2) can be successfully treated with second generation tyrosine kinase inhibitors: A case report and literature review

Biomedical Reports ◽

10.3892/br.2021.1459 ◽

2021 ◽

Vol 15 (4) ◽

Author(s):

Ana Iglesias ◽

Raluca Oancea ◽

Carmen Cotarelo ◽

Eduardo Anguita

Keyword(s):

Case Report ◽

Literature Review ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Second Generation ◽

Kinase Inhibitors

Download Full-text

Tyrosine Kinase Inhibitors in the Elderly: A Case Report and Literature Review on Toxicity Profiles

Archives in Cancer Research ◽

10.21767/2254-6081.1000139 ◽

2017 ◽

Vol 05 (02) ◽

Author(s):

Aileen Deng ◽

Andrew Chapman ◽

Jianqing Lin

Keyword(s):

Case Report ◽

Literature Review ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

The Elderly

Download Full-text

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors

Cancer Research and Treatment ◽

10.4143/crt.2017.378 ◽

2018 ◽

Vol 50 (3) ◽

pp. 908-916 ◽

Cited By ~ 11

Author(s):

Jiyoul Yang ◽

Ok-Jun Lee ◽

Seung-Myoung Son ◽

Chang Gok Woo ◽

Yusook Jeong ◽

...

Keyword(s):

Pleural Effusion ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Malignant Pleural Effusion ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Mutation Status ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

P3.01-29 St.Iv Lung Adenocarcinoma Treated by First-Line EGFR–Tyrosine Kinase Inhibitors-Survival, EGFR Mutation, Histologic Subtype

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1589 ◽

2018 ◽

Vol 13 (10) ◽

pp. S878

Author(s):

T. Gil ◽

G. Czyżewicz ◽

M. Skoczek ◽

P. Wójcik ◽

P. Hajder ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

First Line ◽

Histologic Subtype ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Multi-line treatment with tyrosine kinase inhibitors enabled in 4-year survival for patient with stage IV lung adenocarcinoma: a case report

Annals of Palliative Medicine ◽

10.21037/apm-20-1514 ◽

2020 ◽

Vol 9 (5) ◽

pp. 2-2

Author(s):

Yan Yin ◽

Jianwen Qin

Keyword(s):

Case Report ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Stage Iv ◽

Line Treatment

Download Full-text

Response to tyrosine kinase inhibitors in lung adenocarcinoma with the rare epidermal growth factor receptor mutation S768I and G724S : A case report and literature review

Thoracic Cancer ◽

10.1111/1759-7714.13606 ◽

2020 ◽

Vol 11 (9) ◽

pp. 2743-2748 ◽

Cited By ~ 1

Author(s):

Cuicui Zhang ◽

Li Lin ◽

Ran Zuo ◽

Yajie Wang ◽

Peng Chen

Keyword(s):

Epidermal Growth Factor Receptor ◽

Case Report ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Literature Review ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

TOXICITY AND EFFICACY OF TYROSINE KINASE INHIBITORS IN COMBINATION WITH CHEMOTHERAPY IN PATIENT WITH RESISTANT Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (CASE REPORT AND LITERATURE REVIEW)

Oncohematology ◽

10.17650/1818-8346-2017-12-3-41-49 ◽

2017 ◽

Vol 12 (3) ◽

pp. 41-49

Author(s):

K. I. Zarubina ◽

E. N. Parovichnikova ◽

O. A. Gavrilina ◽

A. N. Sokolov ◽

V. V. Troitskaya ◽

...

Keyword(s):

Case Report ◽

Acute Lymphoblastic Leukemia ◽

Literature Review ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Lymphoblastic Leukemia

Download Full-text

A framework for risk stratification in EGFR+ lung adenocarcinoma treated with tyrosine kinase inhibitors

10.1055/s-0039-1678022 ◽

2019 ◽

Author(s):

P Christopoulos ◽

M Kirchner ◽

F Bozorgmehr ◽

N Magios ◽

AL Volckmar ◽

...

Keyword(s):

Risk Stratification ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors

Download Full-text

.EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research

Pharmacological Research ◽

10.1016/j.phrs.2021.105583 ◽

2021 ◽

pp. 105583

Author(s):

Rui-Fang Dong ◽

Miao-Lin Zhu ◽

Ming-Ming Liu ◽

Yi-Ting Xu ◽

Liu-Liu Yuan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Clinical Research ◽

Tyrosine Kinase Inhibitors ◽

Molecular Mechanisms ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Efficacy of tyrosine kinase inhibitors against lung cancer with EGFR exon 18 deletion: Case report and pooled analysis

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100407 ◽

2021 ◽

pp. 100407

Author(s):

Rafael Rubiera-Pebe ◽

James K. Hicks ◽

Tawee Tanvetyanon

Keyword(s):

Lung Cancer ◽

Case Report ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Pooled Analysis

Download Full-text